Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07636928 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 2, 2026 (before its estimated August 20, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Recruitment opened Study sites: 0 to 1 · Start date changed from estimate of Jun 15, 2026 to Jun 4, 2026v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 15, 2026 to Jun 4, 2026
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to assess the bioavailability, mass balance, pharmacokinetics, metabolism and excretion of radiolabeled (14C) VH4524184.
Trial Details
NCT Number NCT07636928
Lead Sponsor ViiV Healthcare
Conditions HIV Infections
Enrollment 9 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov